Evidence map›Paper›PMID 24477886›Full record

ArticleInfection2014

First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical management.

E Lemmenmeier, P Kohler, T Bruderer, D Goldenberger, G-R Kleger, M Schlegel

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  5. Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  6. Article
  7. Outbreak of KPC-producingPorto biomedical journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

E LemmenmeierDivision of Infectious Diseases and Infection Control, Department of Internal Medicine, Cantonal Hospital St. Gallen, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland, eva.lemmenmeier@kssg.ch.
P Kohler
T Bruderer
D Goldenberger
G-R Kleger
M Schlegel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the epidemiological and clinical features of the first outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) type 2 in Switzerland. The outbreak took place in the medical intensive care unit (MICU) of our tertiary care hospital and affected three severely ill patients. After the implementation of strict infection control measures, no further patients colonised with KPC-KP could be detected by the screening of exposed patients. Successful treatment of patients infected with KPC-KP consisted of a combination therapy of meropenem, colistin and tigecycline.

Indexed as

Disease OutbreaksAdultAgedAnti-Bacterial Agentsbeta-LactamasesColistinElectrophoresis, Gel, Pulsed-FieldGenotypeHumansInfection ControlIntensive Care UnitsKlebsiella InfectionsKlebsiella pneumoniaeMaleMeropenemMiddle AgedAnti-Bacterial Agentsbeta-lactamase KPC-2, Klebsiella pneumoniaebeta-LactamasesColistinMeropenemMinocyclineThienamycinsTigecycline

Identifiers

PMID24477886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.